Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

People with alopecia areata often have lower iron levels than healthy people.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Iron and zinc deficiencies may be treated to help female hair loss.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The most common causes of hair loss in Jordanian children are fungal infections, autoimmune hair loss, and hair shedding after fever, with zinc deficiency also being a notable cause.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

A gluten-free diet stopped a child's hair-eating behavior and suggested she had celiac disease.

Low serum ferritin levels are linked to hair loss in women.

Hereditary elliptocytosis causes elongated red blood cells and can lead to mild or no symptoms.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Low serum ferritin levels are not closely linked to telogen effluvium in women.